Sort   by:  
 Page size 
UnknownNon-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab')2 fragment derived from equine polyclonal antibodies.
Not available
S-EPMC8590615 | biostudies-literature
UnknownCross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines.
Not available
S-EPMC10550992 | biostudies-literature
UnknownHelpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia.
Not available
S-EPMC7711852 | biostudies-literature
UnknownMeasurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Not available
S-EPMC7892614 | biostudies-literature
Sort   by:  
 Page size